Chronic use of statins and aminosalicylic acid and incidence of post-ERCP acute pancreatitis. Preliminary data from the STARK study, a prospective international, multicenter, cohort study

Objectives Acute Pancreatitis is the most frequent complication of Endoscopic Retrograde Cholangiopancreatography (ERCP). Some prophylactic strategies have been investigated to prevent it, such as the use of pancreatic stents or the use of peri-procedural NSAIDs; the incidence of Post-ERCP Acute Pancreatitis (PEP) in patients consuming aminosalicylic acid (ASA), a NSAID, is unclear. Statins are widely used lipid-lowering drugs and recent studies suggest that chronic statin intake may be associated to a lower incidence of acute pancreatitis.

Source: Pancreatology - June 1, 2018 Category: Gastroenterology Authors: Karina C árdenas Jaén, Livia Archibugi, Goran Poropat, Taija Korpela, Jose R. Aparicio, Juan A. Casellas, Emilio Di Giulio, Giuseppe Vanella, Davor Stimac, Goran Hauser, Marianne Udd, Leena Kylänpää, Paolo G. Arcidiacono, Alberto Mariani, Gabriele Ca Tags: Session 14. Endoscopy of the pancreas - free papers Source Type: research